OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
April 14, 2023
Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.
April 13, 2023
The combination of modular facilities and closed processing offers significant advantages in the production of biopharmaceuticals and is becoming a compelling option for manufacturing.
April 12, 2023
Michalle Adkins, director of Life Sciences Consulting at Emerson, discusses the structure of manufacturing organizations and how novel technologies may play a role in operations.
Forecyte Bio has opened a new GMP facility in Shanghai just two months after its sister site in the United States.
The new site will include state-of-the-art cleanroom facilities, laboratories, R&D, and office spaces.
April 10, 2023
Webinar Date/Time: Friday, April 28, 2023 at 11am EDT | 10am CDT | 8am PDT
April 07, 2023
Claudio Fayad, VP of Technology, Process Systems, and Solutions discusses the intersection of automation and data security in the pharma industry.
Lonza and ABL Bio are collaborating on the development and manufacture of bispecific antibody product.
NextPharma has acquired a leading European chewable tablets manufacturing site from Takeda in Asker, Norway.
April 05, 2023
Nathan Pettus, president of Process Systems and Solutions at Emerson, discusses how automation is impacting recent sustainability technologies and solutions.